PATENT CLAIM ANALYSIS

Application Number: 16017173
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates, in part, to compositions and methods for enhancement of an immune response by partial mTOR inhibition, e.g., with low, immune enhancing, doses of an mTOR inhibitor, such as RAD001.

Claim (Index 25):
The method of  claim 22 , wherein the dementia is age-related dementia.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 94.0
- Lexical Diversity: 1.32258
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15292088', '15105074', '14680860', '15105082', '15821229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.76978244452392
- 35 USC 102 Novelty (BERT): 0.610351988087938
- Combined Prediction Score: 0.7538393988803218
- Mean Citation Score: 451.929368
- Max Citation Score: 671.71655
- Similarity Product: 454.4360396176904

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test